[The significance of APC resistance (activated protein C) for clinical practice].
Resistance against the anticoagulatory effect of activated protein C (APC resistance) is the most prevalent hereditary risk factor for venous thromboembolism known today. In this short review, an exemplary casuistic observation from our thrombophilia outpatient ward is presented. The discovery by Dahlbäck et al. in 1993 of hereditary APC resistance as a basis of familial thrombophilia and the molecular characterization of this defect as point mutation in the coagulation factor V gene (FV R506Q- or FV Leiden-mutation) by Bertina and coworkers are discussed. The clinical implications of this thrombophilia and relevant knowledge for daily practice are briefly summarized.
Lämmle
B
B
Hämatologisches Zentrallabor, Inselspital, Bern.
Demarmels Biasiutti
F
F
Wuillemin
W A
WA
Stucki
B
B
Furlan
M
M
D000328:Adult; D001791:Blood Platelet Disorders / Q000175:diagnosis / Q000235:genetics; D004351:Drug Resistance / Q000235:genetics; D005165:Factor V / Q000235:genetics; D005260:Female; D006801:Humans; D010641:Phenotype; D017354:Point Mutation; D011486:Protein C / Q000378:metabolism*; D013923:Thromboembolism / Q000235:genetics / Q000378:metabolism*
D011486:Protein C; D005165:Factor V
Bedeutung der APC-Resistenz für die Praxis.